B
Biosergen AB
STO:BIOSGN
Biosergen AB
STO:BIOSGN
Price:
38.4
SEK
Market Closed
Market Cap:
kr90.2m
Balance Sheet
Balance Sheet Decomposition
Biosergen AB
Biosergen AB
Balance Sheet Decomposition is not available for
Biosergen AB
Biosergen AB
Balance Sheet
Biosergen AB
Biosergen AB
Currency: SEK
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
22
|
29
|
2
|
51
|
|
| Cash |
1
|
22
|
29
|
2
|
51
|
|
| Total Receivables |
1
|
3
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
3
|
1
|
0
|
0
|
|
| Other Current Assets |
3
|
5
|
3
|
5
|
2
|
|
| Total Current Assets |
5
|
29
|
34
|
7
|
53
|
|
| Total Assets |
5
N/A
|
29
+515%
|
34
+15%
|
7
-79%
|
53
+636%
|
|
| Liabilities | ||||||
| Accounts Payable |
5
|
7
|
7
|
2
|
2
|
|
| Accrued Liabilities |
0
|
2
|
4
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
10
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
16
|
9
|
11
|
5
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
16
N/A
|
9
-41%
|
11
+19%
|
5
-54%
|
5
-5%
|
|
| Equity | ||||||
| Common Stock |
3
|
1
|
1
|
1
|
6
|
|
| Retained Earnings |
14
|
20
|
22
|
1
|
42
|
|
| Other Equity |
0
|
0
|
0
|
2
|
49
|
|
| Total Equity |
11
N/A
|
20
N/A
|
23
+13%
|
2
-91%
|
48
+2 178%
|
|
| Total Liabilities & Equity |
5
N/A
|
29
+515%
|
34
+15%
|
7
-79%
|
53
+636%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
